J-147 is primarily investigated for its potential in treating neurodegenerative conditions, especially Alzheimer's disease. It has shown neuroprotective effects in preclinical studies, helping to improve memory and cognitive function in animal models. The compound works by targeting mitochondrial function and reducing oxidative stress in brain cells, which are key factors in aging and neurodegeneration. It also exhibits anti-inflammatory properties and supports the survival of neurons under stress. Due to its ability to cross the blood-brain barrier, J-147 is considered a promising candidate for developing therapies aimed at slowing or reversing the progression of age-related cognitive decline. Research is ongoing to evaluate its long-term efficacy and safety for human use.